Question 1

What specific types of cancer are being studied in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

Question 2

How does JANX008 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of JANX008?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies clinical trial (NCT05783622). Contact the study team or your healthcare provider for specific answers.

What this study is about